Skip to main content

Priligy FDA Approval Status

FDA Approved: No
Brand name: Priligy
Generic name: dapoxetine
Company: ALZA Corporation
Treatment for: Premature Ejaculation

Priligy (dapoxetine) is a short-acting selective serotonin reuptake inhibitor (SSRI) under review for the treatment of premature ejaculation.

Development timeline for Priligy

Oct 26, 2005ALZA Corporation Receives Letter From FDA on Dapoxetine Application
Dec  4, 2004New Drug Application Submitted for Dapoxetine for Premature Ejaculation

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.